{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:28:05Z","timestamp":1760016485106},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2009,9,20]],"date-time":"2009-09-20T00:00:00Z","timestamp":1253404800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1007\/s11894-009-0060-0","type":"journal-article","created":{"date-parts":[[2009,9,19]],"date-time":"2009-09-19T21:16:48Z","timestamp":1253395008000},"page":"400-405","source":"Crossref","is-referenced-by-count":14,"title":["Evolving concepts in Clostridium difficile colitis"],"prefix":"10.1007","volume":"11","author":[{"given":"Naomi G.","family":"Diggs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina M.","family":"Surawicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,9,20]]},"reference":[{"key":"60_CR1","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1128\/CMR.18.2.247-263.2005","volume":"18","author":"D.E. Voth","year":"2005","unstructured":"Voth DE, Ballard JD: Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev 2005, 18:247\u2013263.","journal-title":"Clin Microbiol Rev"},{"key":"60_CR2","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3201\/eid1205.051064","volume":"12","author":"L.C. McDonald","year":"2006","unstructured":"McDonald LC, Owings M, Jernigan JB: Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. Emerg Infect Dis 2006, 12:409\u2013415.","journal-title":"Emerg Infect Dis"},{"key":"60_CR3","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0140-6736(05)67420-X","volume":"366","author":"M. Warmy","year":"2005","unstructured":"Warmy M, Pepin J, Fang A, et al.: Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 2005, 366:1079\u20131084.","journal-title":"Lancet"},{"key":"60_CR4","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1056\/NEJMoa051639","volume":"353","author":"V.G. Loo","year":"2005","unstructured":"Loo VG, Poirier L, Miller MA, et al.: A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005, 353:2442\u20132449.","journal-title":"N Engl J Med"},{"key":"60_CR5","first-page":"1201","volume":"54","author":"Centers for Disease ControlPrevention","year":"2005","unstructured":"Centers for Disease Control and Prevention (CDC): Severe Clostridium difficile-associated disease in populations previously at low risk\u2014four states, 2005. MMWR Morb Mortal Wkly Rep 2005, 54:1201\u20131205.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"60_CR6","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1503\/cmaj.071812","volume":"179","author":"S. Dial","year":"2008","unstructured":"Dial S, Abbas K, Dascal A, et al.: Patterns of antibiotic use and risk of hospital admission because of Clostridium difficile infection. CMAJ 2008, 179:767\u2013772.","journal-title":"CMAJ"},{"issue":"Suppl1","key":"60_CR7","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1086\/521859","volume":"46","author":"R.C. Owens Jr","year":"2008","unstructured":"Owens RC Jr, Donskey CJ, Gaynes RP, et al.: Antimicrobial-associated risk factors for Clostridium difficile infection. Clin Infect Dis 2008, 46(Suppl 1):S19\u2013S31.","journal-title":"Clin Infect Dis"},{"key":"60_CR8","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1086\/496986","volume":"41","author":"J. P\u00e9pin","year":"2005","unstructured":"P\u00e9pin J, Saheb N, Coulombe MA, et al.: Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis 2005, 41:1254\u20131260.","journal-title":"Clin Infect Dis"},{"key":"60_CR9","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.cgh.2006.12.028","volume":"5","author":"M. Issa","year":"2007","unstructured":"Issa M, Vijayapal A, Graham MB, et al.: Impact of Clostridium difficile on inflammatory bowel disease. Clin Gastroenterol Hepatol 2007, 5:345\u2013351.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"60_CR10","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.cgh.2006.12.027","volume":"5","author":"J.F. Rodemann","year":"2007","unstructured":"Rodemann JF, Dubberke ER, Reske KA, et al.: Incidence of Clostridium difficile infection in inflammatory bowel disease. Clin Gastroenterol Hepatol 2007, 5:339\u2013344.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"60_CR11","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1056\/NEJM200002103420604","volume":"342","author":"L. Kyne","year":"2000","unstructured":"Kyne L, Warny M, Quamar A, et al.: Asymptomatic carriage of Clostridium difficile and serum levels of antibody against toxin A. N Engl J Med 2000, 342:390\u2013397.","journal-title":"N Engl J Med"},{"key":"60_CR12","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1111\/j.1572-0241.2007.01275.x","volume":"102","author":"J. Leonard","year":"2007","unstructured":"Leonard J, Marshall JK, Moayyedi P: Systematic review of the risk of enteric infection in patients taking acid suppression. Am J Gastroenterol 2007, 102:2047\u20132056.","journal-title":"Am J Gastroenterol"},{"key":"60_CR13","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1128\/JCM.01503-07","volume":"46","author":"L. Fenner","year":"2008","unstructured":"Fenner L, Widmer AF, Goy G, et al.: Rapid and reliable diagnostic algorithm for detection of Clostridium difficile. J Clin Microbiol 2008, 46:328\u2013330.","journal-title":"J Clin Microbiol"},{"key":"60_CR14","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1086\/522185","volume":"45","author":"L.R. Peterson","year":"2007","unstructured":"Peterson LR, Manson RU, Paule SM, et al.: Detection of toxigenic Clostridium difficile in stool samples by real-time polymerase chain reaction for the diagnosis of C. difficile-associated diarrhea. Clin Infect Dis 2007, 45:1152\u20131160.","journal-title":"Clin Infect Dis"},{"key":"60_CR15","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.diagmicrobio.2009.03.009","volume":"64","author":"S.E. Sharp","year":"2009","unstructured":"Sharp SE, Ivie WM, Buckles MR, et al.: A simple 3-step algorithm for improved laboratory detection of Clostridium difficile toxin without the need for tissue culture cytotoxicity neutralization assays. Diagn Microbiol Infect Dis 2009, 64:344\u2013346.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"60_CR16","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1469-0691.2008.01999.x","volume":"14","author":"S.B. Debast","year":"2008","unstructured":"Debast SB, van Kregten E, Oskam KM, et al.: Effect on diagnostic yield of repeated stool testing during outbreaks of Clostridium difficile-associated disease. Clin Microbiol Infect 2008, 14:622\u2013624.","journal-title":"Clin Microbiol Infect"},{"key":"60_CR17","doi-asserted-by":"crossref","unstructured":"Nemat H, Khan R, Ashraf M, et al.: Diagnostic value of repeated enzyme immunoassays in Clostridium difficile infection. Am J Gastroenterol, 2009, doi: 10.1038\/ajg.2009.174 (Epub ahead of print).","DOI":"10.1038\/ajg.2009.174"},{"key":"60_CR18","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1002\/ibd.20500","volume":"14","author":"M. Issa","year":"2008","unstructured":"Issa M, Ananthakrishnan A, Binion D: Clostridium difficile and inflammatory bowel disease. Inflamm Bowel Dis 2008, 14:1432\u20131442.","journal-title":"Inflamm Bowel Dis"},{"key":"60_CR19","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1503\/cmaj.1041104","volume":"171","author":"J. Pepin","year":"2004","unstructured":"Pepin J, Valiquette L, Alary ME, et al.: Clostridium difficile-associated diarrhea in a region of Quebec from 1991-2003: a changing pattern of disease severity. CMAJ 2004, 171:466\u2013472.","journal-title":"CMAJ"},{"key":"60_CR20","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/QCO.0b013e32818be71d","volume":"20","author":"E.J. Kuijpers","year":"2007","unstructured":"Kuijpers EJ, van Dissel JT, Wilcox MH: Clostridium difficile: changing epidemiology and new treatment options. Curr Opin Infect Disease 2007, 20:376\u2013383.","journal-title":"Curr Opin Infect Disease"},{"key":"60_CR21","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1086\/510391","volume":"44","author":"B. Hubert","year":"2007","unstructured":"Hubert B, Loo VG, Bourgault AM, et al.: A portrait of the geographic dissemination of the Clostridium difficile North American pulse-field type 1 strain and the epidemiology of C. difficile-associated disease in Quebec. Clin Infect Dis 2007, 44:238\u2013244.","journal-title":"Clin Infect Dis"},{"key":"60_CR22","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1086\/430315","volume":"40","author":"J. Pepin","year":"2005","unstructured":"Pepin J, Alary ME, Valiquette L, et al.: Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. Clin Infect Dis 2005, 40:1591\u20131597.","journal-title":"Clin Infect Dis"},{"key":"60_CR23","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1086\/501368","volume":"193","author":"B. Geric","year":"2006","unstructured":"Geric B, Carman RJ, Rupnik M, et al.: Binary toxin-producing, large clostridial toxin-negative Clostridium difficile strains are enterotoxic but do not cause disease in hamsters. J Infect Dis 2006, 193:1143\u20131150.","journal-title":"J Infect Dis"},{"key":"60_CR24","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa051590","volume":"353","author":"L.C. McDonald","year":"2005","unstructured":"McDonald LC, Killgore GE, Thompson A, et al.: An epidemic, toxin-gene variant strain of Clostridium difficile. N Engl J Med 2005, 353:503\u2013524.","journal-title":"N Engl J Med"},{"key":"60_CR25","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1086\/502539","volume":"26","author":"C.A. Muto","year":"2005","unstructured":"Muto CA, Pokrywka M, Shutt K, et al.: A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol 2005, 26:273\u2013280.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"60_CR26","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1097\/01.mcg.0000139057.05297.d6","volume":"38","author":"A.M. Meyer","year":"2004","unstructured":"Meyer AM, Ramzan NN, Loftus EV Jr, et al.: The diagnostic yield of stool pathogen studies during relapses of inflammatory bowel disease. J Clin Gastroenterol 2004, 38:772\u2013775.","journal-title":"J Clin Gastroenterol"},{"key":"60_CR27","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1136\/gut.2007.128231","volume":"57","author":"A.N. Ananthakrishnan","year":"2008","unstructured":"Ananthakrishnan AN, McGinley EL, Binion DG: Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease. Gut 2008, 57:205\u2013210.","journal-title":"Gut"},{"key":"60_CR28","first-page":"CD004610","volume":"3","author":"R. Nelson","year":"2007","unstructured":"Nelson R: Antibiotic treatment for Clostridium difficile-associated diarrhea in adults. Cochrane Database Syst Rev 2007, 3:CD004610.","journal-title":"Cochrane Database Syst Rev"},{"key":"60_CR29","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1086\/430311","volume":"40","author":"D.M. Musher","year":"2005","unstructured":"Musher DM, Aslam S, Logan N, et al.: Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole. Clin Infect Dis 2005, 40:1586\u20131590.","journal-title":"Clin Infect Dis"},{"key":"60_CR30","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/00004836-200405000-00005","volume":"38","author":"A. Fernandez","year":"2004","unstructured":"Fernandez A, Anand G, Friedenberg F: Factors associated with failure of metronidazole in Clostridium difficile-associated disease. J Clin Gastroenterol 2004, 38:414\u2013418.","journal-title":"J Clin Gastroenterol"},{"key":"60_CR31","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.cgh.2008.06.024","volume":"6","author":"M.Y. Hu","year":"2008","unstructured":"Hu MY, Maroo S, Kyne L, et al.: A prospective study of risk factors and historical trends in metronidazole failure for Clostridium difficile infection. Clin Gastroenterol Hepatol 2008, 6:1354\u20131360.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"60_CR32","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1086\/519265","volume":"45","author":"F.A. Zar","year":"2007","unstructured":"Zar FA, Bakkanagari SR, Moorthi KM, et al.: A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis 2007, 45:302\u2013307.","journal-title":"Clin Infect Dis"},{"key":"60_CR33","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1053\/j.gastro.2006.02.044","volume":"130","author":"S. Maroo","year":"2006","unstructured":"Maroo S, Lamont JT: Recurrent Clostridium difficile. Gastroenterology 2006, 130:1311\u20131316.","journal-title":"Gastroenterology"},{"key":"60_CR34","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1111\/j.1572-0241.2002.05839.x","volume":"97","author":"L.V. McFarland","year":"2002","unstructured":"McFarland LV, Elmer GW, Surawicz CM: Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease. Am J Gastroentol 2002, 97:1769\u20131775.","journal-title":"Am J Gastroentol"},{"key":"60_CR35","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0140-6736(00)03592-3","volume":"357","author":"L. Kyne","year":"2001","unstructured":"Kyne L, Warny M, Quama A, et al.: Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea. Lancet 2001, 357:189\u2013193.","journal-title":"Lancet"},{"key":"60_CR36","doi-asserted-by":"crossref","unstructured":"Pillai A, Nelson RL: Probiotics for treatment of Clostridium difficile-associated colitis in adults. Cochrane Database Syst Rev 2008, CD004611.","DOI":"10.1002\/14651858.CD004611.pub2"},{"key":"60_CR37","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1001\/jama.1994.03510480037031","volume":"271","author":"L.V. McFarland","year":"1994","unstructured":"McFarland LV, Surawicz CM, Greenberg RN, et al.: A randomized, placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA 1994, 271:1913\u20131918.","journal-title":"JAMA"},{"key":"60_CR38","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1086\/318130","volume":"31","author":"C.M. Surawicz","year":"2000","unstructured":"Surawicz CM, McFarland LV, Greenberg RN, et al.: The search for a better treatment for recurrent Clostridium difficile disease: Use of high-dose vancomycin with Saccharomyces boulardii. CID 2000, 31:1012\u20131017.","journal-title":"CID"},{"key":"60_CR39","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1099\/jmm.0.46096-0","volume":"54","author":"S.J. Lawrence","year":"2005","unstructured":"Lawrence SJ, Korzenik JR, Mundy LM: Probiotics for recurrent Clostridium difficile disease. J Med Microbiol 2005, 54:906\u2013906.","journal-title":"J Med Microbiol"},{"key":"60_CR40","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/00365540310010985","volume":"35","author":"M. Wullt","year":"2003","unstructured":"Wullt M, H\u00e4gslatt ML, Odenholt I: Lactobacillus plantarum 299v for the treatment of recurrent Clostridium difficile-associated diarrhoea: a double-blind, placebo-controlled trial. Scand J Infect Dis 2003, 35:365\u2013367.","journal-title":"Scand J Infect Dis"},{"key":"60_CR41","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1111\/j.1572-0241.2008.02198.x","volume":"103","author":"M.R. Jaber","year":"2008","unstructured":"Jaber MR, Olafsson S, Fung WL, Reeves ME: Clinical review of management of fulminant Clostridium difficile infection. Am J Gastroenterol 2008, 103:3195\u20133203.","journal-title":"Am J Gastroenterol"},{"key":"60_CR42","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11908-009-0004-8","volume":"11","author":"J.G. Bartlett","year":"2009","unstructured":"Bartlett JG: New antimicrobial agents for patients with Clostridium difficile infections. Curr Infect Dis Rep 2009, 11:21\u201328.","journal-title":"Curr Infect Dis Rep"},{"key":"60_CR43","volume-title":"Program and Abstracts of the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy","author":"T.J. Louie","year":"2007","unstructured":"Louie TJ, Gerson M, Grimard D, et al.: Results of a phase III study comparing tolevamer, vancomycin and metronidazole in Clostridium difficile-associated diarrhea (CDAD). Program and Abstracts of the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: ASM Press; 2007. Abstract K-4259."},{"key":"60_CR44","doi-asserted-by":"crossref","unstructured":"O\u2019Horo J, Safdar N: The role of immunoglobulin for the treatment of Clostridium difficile infection: a systematic review. Int J Infect Dis 2009 (Epub ahead of print).","DOI":"10.1016\/j.ijid.2008.11.012"},{"key":"60_CR45","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1053\/j.gastro.2004.11.004","volume":"128","author":"S. Sougioultzis","year":"2005","unstructured":"Sougioultzis S, Kyne L, Drudy D, et al.: Clostridium difficile toxoid vaccine in recurrent C. difficile-associated diarrhea. Gastroenterology 2005, 128:764\u2013770.","journal-title":"Gastroenterology"},{"issue":"Suppl1","key":"60_CR46","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1086\/521861","volume":"46","author":"D.N. Gerding","year":"2008","unstructured":"Gerding DN, Muto CA, Owens RC Jr: Measures to control and prevent Clostridium difficile infection. Clin Infect Dis 2008, 46(Suppl 1):S43\u2013S49.","journal-title":"Clin Infect Dis"},{"key":"60_CR47","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0002-9343(96)90008-X","volume":"100","author":"M.H. Sawmore","year":"1996","unstructured":"Sawmore MH, Venkataraman L, DeGirolami PC, et al.: Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial Clostridium difficile diarrhea. Am J Med 1996, 100:32\u201340.","journal-title":"Am J Med"},{"key":"60_CR48","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1086\/318149","volume":"31","author":"J.L. Mayfield","year":"2000","unstructured":"Mayfield JL, Leet T, Miller J, Mundy LM: Environmental control to reduce transmission of Clostridium difficile. Clin Infect Dis 2000, 31:995\u20131000.","journal-title":"Clin Infect Dis"},{"key":"60_CR49","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1086\/510393","volume":"44","author":"T.H. Dellit","year":"2007","unstructured":"Dellit TH, Owens RC, McGowan JE Jr, et al.: IDSA\/SHEA guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007, 44:159\u2013177.","journal-title":"Clin Infect Dis"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-009-0060-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11894-009-0060-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-009-0060-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T00:41:55Z","timestamp":1633912915000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11894-009-0060-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,20]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["60"],"URL":"https:\/\/doi.org\/10.1007\/s11894-009-0060-0","relation":{},"ISSN":["1522-8037","1534-312X"],"issn-type":[{"value":"1522-8037","type":"print"},{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,20]]}}}